We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
296 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Taiwan AlbuRx 20 TW human albumin 200g/L (20% w/v) solution for intravenous infusion vial.
-
Cancellation by sponsorRequested by CSL Behring Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Hong Kong Albumex 20 NexGen Human Albumin 200g/L Solution for Intravenous Infusion.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL New Zealand Alburex 20 NZ, Solution for infusion 20%.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Hong Kong Aleviate Human Coagulation Factor VIII 500 IU/von Willebrand factor 1000 IU complex, Powder for injection (50 IU/mL FVIII).
-
Prescription medicine registrationActive ingredients: etranacogene dezaparvovec.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Hong Kong Aleviate Human Coagulation Factor VIII 250 IU/von Willebrand factor 500 IU complex, Powder for injection (50 IU/mL FVIII).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL New Zealand Hizentra NZ Human Normal Immunoglobulin (20%) solution for subcutaneous injection.
-
Jan-2024Prescription medicine evaluationActive ingredient: garadacimab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL New Zealand Privigen NZ normal immunoglobulin (human) 100 g/L, 10% solution for intravenous infusion.